Nucleophagy: How Cells Eat Their Own Nucleus to Fight Aging and Disease
A comprehensive review reveals how mammalian cells selectively degrade damaged nuclear components to preserve genomic stability and health.
Summary
Nucleophagy is a specialized form of autophagy in which cells selectively target and degrade damaged or dysfunctional nuclear components — including nuclear proteins like lamins, SIRT1, and histones, DNA-protein crosslinks, micronuclei, and chromatin fragments. This 2025 review in Autophagy synthesizes current knowledge of the molecular mechanisms, cargo-selection pathways, and regulatory networks governing nucleophagy in mammalian cells. The authors highlight how impaired nucleophagy contributes to aging, cancer, neurodegeneration, autoimmune disorders, and neurological injury. By clarifying how cells maintain nuclear integrity through selective degradation, the review opens new avenues for therapeutic strategies targeting nucleophagy in human disease.
Detailed Summary
The nucleus is the cell's command center, housing genetic material and orchestrating growth, metabolism, protein synthesis, and division. Maintaining nuclear integrity is therefore essential for cellular and organismal health. When nuclear components become damaged or dysfunctional, their accumulation can drive genomic instability, inflammation, and disease. Nucleophagy — the selective autophagic degradation of nuclear material — has emerged as a critical quality-control mechanism, but its mammalian mechanisms have been incompletely characterized until recently.
This 2025 review, published in Autophagy, provides a comprehensive synthesis of mammalian nucleophagy, covering its molecular processes, cargo-selection machinery, and regulatory pathways. The authors describe how nuclear material — including lamins (structural proteins of the nuclear envelope), the longevity regulator SIRT1, histones, DNA-protein crosslinks (such as TOP1 cleavage complexes), micronuclei, and chromatin fragments — are recognized and delivered to autophagic machinery for degradation. Key receptors and adaptors bearing LC3-interacting region (LIR) motifs facilitate selective capture of nuclear cargo. The review also discusses the roles of the ESCRT complex in nuclear envelope integrity and the interplay between nucleophagy and other quality-control pathways including chaperone-mediated autophagy (CMA).
Regulation of nucleophagy is linked to major cellular signaling networks. MTORC1 suppresses autophagy under nutrient-replete conditions, while AMPK promotes it under stress. The review outlines how genotoxic stress, DNA damage, and nuclear envelope rupture serve as triggers for nucleophagic responses. Upstream regulatory signals, including those from PI3K-PtdIns3P pathways and ATG protein complexes, are discussed in the context of nuclear cargo selection.
From a disease perspective, the authors systematically evaluate impaired nucleophagy across multiple pathologies. In cancer, dysfunctional nucleophagy can both suppress and promote tumorigenesis depending on context — for example, micronuclei clearance through nucleophagy may limit genomic instability, while some tumor cells exploit autophagic pathways for survival. In neurodegeneration, including conditions related to dentatorubral-pallidoluysian atrophy (DRPLA), accumulation of damaged nuclear proteins due to impaired nucleophagy accelerates pathology. Autoimmune disorders may arise when nuclear debris evades degradation and triggers innate immune sensing. The review also addresses nucleophagy's role in aging, noting that declining nucleophagic activity correlates with nuclear lamina deterioration and genomic instability characteristic of aged cells.
The therapeutic implications are significant. Pharmacological modulation of nucleophagy — through autophagy inducers, mTOR inhibitors, or targeted enhancement of specific cargo-receptor interactions — represents a promising strategy for diseases driven by nuclear damage accumulation. However, the authors caution that the dual roles of autophagy in cancer and the context-dependency of nucleophagic effects must be carefully considered in therapeutic development. Overall, this review establishes nucleophagy as a central pillar of nuclear quality control with broad relevance to aging biology and disease.
Key Findings
- Nucleophagy selectively degrades damaged nuclear components including lamins, SIRT1, histones, micronuclei, and DNA-protein crosslinks.
- LIR motif-containing receptors and ESCRT complexes are central to nuclear cargo recognition and autophagic delivery.
- Impaired nucleophagy is implicated in aging, cancer, neurodegeneration, autoimmune disease, and neurological injury.
- MTORC1 and AMPK are key upstream regulators balancing nucleophagic activity in response to nutrient and stress signals.
- Micronuclei clearance via nucleophagy may limit chromosomal instability, offering a tumor-suppressive function.
Methodology
This is a comprehensive narrative review synthesizing published literature on mammalian nucleophagy mechanisms, regulation, and disease relevance. The authors draw on molecular, cellular, and disease-model studies across cancer, neurodegeneration, aging, and autoimmunity. No original experimental data are presented; conclusions are based on critical evaluation of existing evidence.
Study Limitations
As a review article, this work does not present new experimental data and is subject to the limitations of the primary studies cited. Many mechanistic insights derive from yeast or in vitro mammalian models, and direct in vivo evidence for specific nucleophagy pathways in human disease remains limited. The therapeutic implications discussed are largely speculative and require validation in clinical settings.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.